RNS Number:8964C
Tepnel Life Sciences PLC
21 December 1999
       
       JOINT VENTURE WITH UNICS COMPLEMENTS TEPNEL'S SYSTEMS DEVELOPMENT
                                 CAPABILITIES
   
   Tepnel Life Sciences PLC ("Tepnel" or the "Company") announces that  it
   has  extended its systems development capabilities by entering  into  a
   commercial  joint venture with Unics Automation PTE Ltd ("Unics"),  the
   Singapore-based   product  development  and   engineering   group   for
   prototype  development and final instrument manufacture.   Unics  is  a
   subsidiary of MMI Holdings Limited ("MMI").  MMI is listed on the  Main
   Board of the Stock Exchange of Singapore.
   
   The  commercial  joint  venture enables the two organisations  to  work
   together  in developing automated systems for third party companies  in
   the  life  science  research,  clinical diagnostics  and  food  testing
   markets.
   
   Under  the  exclusive  agreement, Tepnel will be  responsible  for  the
   sales  and  marketing  activity  and Unics  will  design,  develop  and
   produce  the  instrumentation.  The joint venture, (which excludes  the
   current  DNA  purification  system and any other  systems  designed  by
   Tepnel),  will  involve profit sharing based upon the size,  price  and
   commercial risk of each project.
   
   Tepnel  and Unics have already worked together very successfully  on  a
   DNA  purification  system prototype which was  designed  and  built  by
   Unics  in  only  10  weeks.  This instrument,  exhibited  at  the  AACC
   Exhibition  (American  Association  for  Clinical  Chemistry)  in   New
   Orleans  in  July 1999, received positive feedback from both  end-users
   and  potential  commercial  partners. Unics  provide  Tepnel  with  the
   engineering  design, manufacturing skills and software capabilities  it
   requires  to  combine  with its own DNA analysis expertise  to  develop
   automated  systems for the life science research, clinical  diagnostics
   and  food testing markets.  This partnering will be maintained for  all
   future Tepnel instrumentation projects.
   
   Peter  Raymond,  Chairman  and  Acting  CEO  of  Tepnel,  said:   "This
   commercial  venture  enables  Tepnel  to  offer  a  design  and   build
   instrumentation  service for the generation of sales and  profits  from
   third  party  contracts, whilst consolidating the  systems  development
   capabilities already created for future Tepnel instrumentation".
   
   For further information, please contact:
   
   Tepnel Life Sciences PLC                           Tel:   0161 445 9457
   Peter Raymond, Chairman
   Mike Billingham, Commercial Director
   
   Rawlings Financial PR Limited                      Tel:   01904 621 914
   Catriona Valentine
   
   Notes to editors:
   
   Established in 1993, Unics specialises in robotic systems  integration,
   cleanroom automation and the fabrication of  precision  handling   and
   assembly  systems  for  4  major industries  ie biotech/life-sciences/
   medical, electronics,  data storage and defence.  The company's 30,000 
   square feet facility  houses  a design group supported by CAD stations,
   a tool-makers workshop,  a  tool  assembly group and the core equipment
   manufacturing and fabrication unit.
   
   Unics is a subsidiary of MMI Holdings Limited,  a  mechanical  systems
   contract manufacturing and  integration  group.   MMI is listed on the
   Main Board of the Stock Exchange of Singapore, is a component stock of
   the Straits Times 55 Index and has been granted Central Provident Fund
   trustee stock status.

END

JVEFEDFIFUUUFFE


Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Ted Baker Charts.
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Ted Baker Charts.